1999 - Member of the National Academy of Medicine (NAM)
1996 - Fellow of the American Academy of Arts and Sciences
1995 - Alfred P. Sloan Jr. Prize, General Motors Cancer Research Foundation
1993 - Member of the National Academy of Sciences
Ed Harlow spends much of his time researching Molecular biology, Retinoblastoma protein, Cell biology, Retinoblastoma-Like Protein p107 and Cell cycle. He has included themes like Histone H2A, Histone H1, Virus, Epitope and Monoclonal antibody in his Molecular biology study. The Retinoblastoma protein study combines topics in areas such as E2F1, E2F, Tumor suppressor gene, Retinoblastoma-like protein 1 and Gene product.
His Cell biology study incorporates themes from Cyclin-dependent kinase, Cyclin A and Binding site. His Retinoblastoma-Like Protein p107 study integrates concerns from other disciplines, such as Retinoblastoma and Transformation. His Cell cycle study combines topics from a wide range of disciplines, such as Cell culture, Kinase and Cell growth.
His primary areas of study are Molecular biology, Cell biology, Retinoblastoma protein, Biochemistry and E2F. His study in Molecular biology is interdisciplinary in nature, drawing from both Cell culture, Immunoprecipitation, Retinoblastoma-Like Protein p107, Antigen and Monoclonal antibody. In his research, Antigen retrieval is intimately related to Epitope, which falls under the overarching field of Monoclonal antibody.
His studies in Cell biology integrate themes in fields like Cell cycle and Cyclin-dependent kinase. His research in Cyclin-dependent kinase intersects with topics in Cyclin-dependent kinase 1, Cyclin D1, Peptide sequence and Cyclin. His study looks at the relationship between Retinoblastoma protein and fields such as Retinoblastoma-like protein 1, as well as how they intersect with chemical problems.
The scientist’s investigation covers issues in Chromatography, Molecular biology, Biochemistry, Antigen and Antibody. Ed Harlow has researched Molecular biology in several fields, including Staining, Sonication, Immunoprecipitation and Cell biology. His Cell biology research is multidisciplinary, relying on both Cell, Cell cycle, Cell growth, Cancer cell and Small hairpin RNA.
His study in E2F and Retinoblastoma protein is carried out as part of his studies in Cell cycle. Ed Harlow combines subjects such as Epitope and Paraformaldehyde with his study of Biochemistry. His work deals with themes such as Cancer research and Kinase, which intersect with Tumor suppressor gene.
His primary scientific interests are in Kinase, Cell biology, Cancer research, Small hairpin RNA and Cell cycle. His Kinase research integrates issues from Cancer cell, Cell, Cell culture and Gene. His Cell biology research is multidisciplinary, incorporating elements of Eukaryotic DNA replication, Complementary DNA, Molecular biology, GTP' and Genetic screen.
Ed Harlow undertakes interdisciplinary study in the fields of Molecular biology and Dynamin through his research. His is involved in several facets of Cell cycle study, as is seen by his studies on E2F and Retinoblastoma protein. His specific area of interest is Retinoblastoma protein, where Ed Harlow studies Retinoblastoma-Like Protein p107.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Antibodies: A Laboratory Manual
Ed Harlow;David Lane.
Using Antibodies: A Laboratory Manual
Ed Harlow;David Lane.
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
Nicholas Dyson;Peter M. Howley;Karl Munger;Ed Harlow.
New functional activities for the p21 family of CDK inhibitors.
Joshua Labaer;Michelle D. Garrett;Lauren F. Stevenson;Joyce M. Slingerland.
Genes & Development (1997)
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product.
Peter Whyte;Peter Whyte;Karen J. Buchkovich;Jonathan M. Horowitz;Stephen H. Friend;Stephen H. Friend.
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.
K Münger;B A Werness;N Dyson;W C Phelps.
The EMBO Journal (1989)
The retinoblastoma protein is phosphorylated during specific phases of the cell cycle.
Karen Buchkovich;Linda A. Duffy;Ed Harlow.
Distinct roles for cyclin-dependent kinases in cell cycle control
S van den Heuvel;E Harlow.
p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
Li-Huei Tsai;Ivana Delalle;Verne S. Caviness;Teresa Chae.
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Diane C. Fingar;Sofie Salama;Christina Tsou;Ed Harlow.
Genes & Development (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: